These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte. Chan AY; Soltys CL; Young ME; Proud CG; Dyck JR J Biol Chem; 2004 Jul; 279(31):32771-9. PubMed ID: 15159410 [TBL] [Abstract][Full Text] [Related]
44. AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3. Paquette M; El-Houjeiri L; C Zirden L; Puustinen P; Blanchette P; Jeong H; Dejgaard K; Siegel PM; Pause A Autophagy; 2021 Dec; 17(12):3957-3975. PubMed ID: 33734022 [TBL] [Abstract][Full Text] [Related]
45. Expression of an active LKB1 complex in cardiac myocytes results in decreased protein synthesis associated with phenylephrine-induced hypertrophy. Noga AA; Soltys CL; Barr AJ; Kovacic S; Lopaschuk GD; Dyck JR Am J Physiol Heart Circ Physiol; 2007 Mar; 292(3):H1460-9. PubMed ID: 17098823 [TBL] [Abstract][Full Text] [Related]
46. Beta 3 adrenoreceptors protect from hypertrophic remodelling through AMP-activated protein kinase and autophagy. Dubois-Deruy E; Gelinas R; Beauloye C; Esfahani H; Michel LYM; Dessy C; Bertrand L; Balligand JL ESC Heart Fail; 2020 Jun; 7(3):920-932. PubMed ID: 32154661 [TBL] [Abstract][Full Text] [Related]
53. Nitric Oxide-cGMP-PKG Pathway Acts on Orai1 to Inhibit the Hypertrophy of Human Embryonic Stem Cell-Derived Cardiomyocytes. Wang Y; Li ZC; Zhang P; Poon E; Kong CW; Boheler KR; Huang Y; Li RA; Yao X Stem Cells; 2015 Oct; 33(10):2973-84. PubMed ID: 26269433 [TBL] [Abstract][Full Text] [Related]
54. CaMKIIδ meditates phenylephrine induced cardiomyocyte hypertrophy through store-operated Ca Ji Y; Guo X; Zhang Z; Huang Z; Zhu J; Chen QH; Gui L Cardiovasc Pathol; 2017; 27():9-17. PubMed ID: 27940402 [TBL] [Abstract][Full Text] [Related]
55. Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation. Zhou Y; He X; Chen Y; Huang Y; Wu L; He J Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):394-9. PubMed ID: 26519882 [TBL] [Abstract][Full Text] [Related]
56. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Cao DJ; Wang ZV; Battiprolu PK; Jiang N; Morales CR; Kong Y; Rothermel BA; Gillette TG; Hill JA Proc Natl Acad Sci U S A; 2011 Mar; 108(10):4123-8. PubMed ID: 21367693 [TBL] [Abstract][Full Text] [Related]
57. Oleanonic acid ameliorates pressure overload-induced cardiac hypertrophy in rats: The role of PKCζ-NF-κB pathway. Gao H; Liu H; Tang T; Huang X; Wang D; Li Y; Huang P; Peng Y Mol Cell Endocrinol; 2018 Jul; 470():259-268. PubMed ID: 29138023 [TBL] [Abstract][Full Text] [Related]
58. Chronic blockade of class I PI3-kinase attenuates Ang II-induced cardiac hypertrophy and autophagic alteration. Yan W; Guo LR; Zhang Q; Sun WZ; O'Rourke ST; Liu KX; Sun CW Eur Rev Med Pharmacol Sci; 2015; 19(5):772-83. PubMed ID: 25807429 [TBL] [Abstract][Full Text] [Related]
59. Quercetin regulates the sestrin 2-AMPK-p38 MAPK signaling pathway and induces apoptosis by increasing the generation of intracellular ROS in a p53-independent manner. Kim GT; Lee SH; Kim JI; Kim YM Int J Mol Med; 2014 Apr; 33(4):863-9. PubMed ID: 24535669 [TBL] [Abstract][Full Text] [Related]
60. Icariside II attenuates cardiac remodeling via AMPKα2/mTORC1 in vivo and in vitro. Liu XY; Liao HH; Feng H; Zhang N; Yang JJ; Li WJ; Chen S; Deng W; Tang QZ J Pharmacol Sci; 2018 Sep; 138(1):38-45. PubMed ID: 30241784 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]